Skip to main content

AXCELIS TECHNOLOGIES INC

corporate_fare Company Profile

AXCELIS TECHNOLOGIES INC

ACLS·NASDAQ·Technology·CIK 0001113232

Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. The company sells its products to leading semiconductor chip manufacturers globally. Its primary product line is the Purion family of products, which are ion implanters. The ion implantation business accounted for 98.2% of Axcelis' revenue in 2025. The remaining 1.8% of revenue came from aftermarket sales related to other legacy processing systems. Beyond equipment sales, Axcelis provides a range of aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Axcelis' business began in 1978, and its current corporate entity was incorporated in Delaware in 1995. The company is headquartered in Beverly, Massachusetts. In 2025, Axcelis reported total revenue of $839.0 million, down from $1,017.9 million in 2024. Systems revenue specifically was $571.0 million in 2025, compared to $782.6 million in 2024. The gross margin percentage for 2025 was 44.9%, a slight increase from 44.7% in 2024. Operating profit for 2025 was $119.3 million, compared to $210.8 million in 2024. Net income in 2025 was $120.2 million, compared to $201.0 million in 2024.

AXCELIS TECHNOLOGIES INC (NASDAQ:ACLS) is a publicly traded company in the Technology sector. Wiseek monitors ACLS SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Axcelis Q1 Diluted EPS Plunges 66% to $0.30, Net Income Down 68%
  • Axcelis Technologies Reports Sharp Q1 GAAP Profit Decline and Margin Contraction Amidst Higher Merger-Related Costs
  • Axcelis Beats Q1 Revenue, EPS Estimates on Strong Memory Demand
  • Axcelis Technologies Reports Q1 Beat, Strong Memory Demand, and Positive Q2 Outlook
  • Axcelis Provides Positive Update on Veeco Merger Progress, Expects H2 2026 Close

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$839.05M
Net Income
$120.24M
Diluted EPS
$3.80
Op. Cash Flow
$118.31M
Free Cash Flow
$107.01M
Gross Profit
$376.85M
Operating Income
$119.31M
Cash & Equivalents
$145.45M
Debt / Equity
0.00×
Net Margin
14.3%
Shares Outstanding
30.72M sh
Source: 10-K · filed 2026-02-26 · accession 0001104659-26-020461
Browse all tickers starting with A →
$180.01 -0.11% today
52-week range · as of 2026-05-08 $55.93 – $171.61
Market cap
$5.54B
Volume
641.3K (1.0× avg)
3-mo avg 652.9K
Live data · 2026-06-14 03:51 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ACLS - Latest Insights

ACLS
May 08, 2026, 12:21 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $160.56
Real-time Price: $180.01 info
Change: +$19.45 (+12%) info
Market Cap: $5.536B info
ACLS
May 08, 2026, 12:20 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $160.56
Real-time Price: $180.01 info
Change: +$19.45 (+12%) info
Market Cap: $5.536B info
ACLS
May 07, 2026, 4:44 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $153.17
Real-time Price: $180.01 info
Change: +$26.84 (+18%) info
Market Cap: $5.536B info
ACLS
May 07, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $155.67
Real-time Price: $180.01 info
Change: +$24.34 (+16%) info
Market Cap: $5.536B info
ACLS
Apr 29, 2026, 4:15 PM EDT
Filing Type: 425
Importance Score:
7
Price at Filing: $133.59
Real-time Price: $180.01 info
Change: +$46.42 (+35%) info
Market Cap: $5.536B info
ACLS
Mar 31, 2026, 7:28 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $90.43
Real-time Price: $180.01 info
Change: +$89.58 (+99%) info
Market Cap: $5.536B info
ACLS
Mar 12, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $85.18
Real-time Price: $180.01 info
Change: +$94.83 (+111%) info
Market Cap: $5.536B info
ACLS
Mar 12, 2026, 4:36 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $85.18
Real-time Price: $180.01 info
Change: +$94.83 (+111%) info
Market Cap: $5.536B info
ACLS
Feb 26, 2026, 3:48 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $83.57
Real-time Price: $180.01 info
Change: +$96.44 (+115%) info
Market Cap: $5.536B info
ACLS
Feb 17, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $85.00
Real-time Price: $180.01 info
Change: +$95.01 (+112%) info
Market Cap: $5.536B info
ACLS
Feb 12, 2026, 5:22 PM EST
Filing Type: 425
Importance Score:
8
Price at Filing: $95.00
Real-time Price: $180.01 info
Change: +$85.01 (+89%) info
Market Cap: $5.536B info
ACLS
Feb 06, 2026, 4:40 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $86.84
Real-time Price: $180.01 info
Change: +$93.17 (+107%) info
Market Cap: $5.536B info
ACLS
Feb 02, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $86.49
Real-time Price: $180.01 info
Change: +$93.52 (+108%) info
Market Cap: $5.536B info
ACLS
Jan 28, 2026, 5:18 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $91.23
Real-time Price: $180.01 info
Change: +$88.78 (+97%) info
Market Cap: $5.536B info
ACLS
Jan 28, 2026, 5:18 PM EST
Filing Type: 425
Importance Score:
8
Price at Filing: $91.23
Real-time Price: $180.01 info
Change: +$88.78 (+97%) info
Market Cap: $5.536B info